Coley Pharmaceutical drug given the ax originally appeared on BloggingStocks on Wed, 20 Jun 2007 17:00:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Medarex Inc (NASDAQ: MEDX) was initiated with a Positive rating at Susquehanna. The firm said Medarex has multiple drivers include a potential buyout by one of its existing partners, as well as clinical progress and the success of its technology platform in monoclonal antibody therapeutics.
• Susquehanna also initiated shares of Dyax Corporation (NASDAQ: DYAX), Millennium Pharmaceuticals Inc (NASDAQ: MLNM), and Idera Pharmaceuticals Inc (AMEX: IDP) with Neutral ratings and Dynavax Technologies Corporation (NASDAQ: DVAX) and Coley Pharmaceutical Group Inc (NASDAQ: COLY) with Positive ratings.
• Rayonier Inc (NYSE: RYN), Plum Creek Timber Company Inc (NYSE: PCL) and Weyerhaeuser Company (NYSE: WY) were initiated with Buy ratings at Merrill Lynch.
• Kona Grill was initiated with an Outperform rating at Cowen. The firm believes Kona can grow its asset base 10-fold at strong store-level cash-on-cash ROICs.

• Jefferies initiated shares of Input/Output Inc (NYSE: IO) with a Buy rating and $19 target.
• Goldman Sachs initiated shares of Minerals Technologies Inc (NYSE: MTX) with a Buy rating and $80 target.
• JP Morgan initiated shares of Orexigen Therapeutics Inc (NASDAQ: OREX) with an Overweight rating and is positive on the company's obesity pipeline.

Analyst initiations 6-07-07: Pharmaceutical companies, timber and KONA originally appeared on BloggingStocks on Thu, 07 Jun 2007 11:18:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• CIBC considers shares of Burger King Holdings (NYSE: BKC) to still be attractive and has above-consensus estimates, starting shares with an Sector Outperformer rating. The firm believes increased operating hours and breakfast value meals will drive results, while cost savings should help margins.

• JMP Securities believes there is plenty of room for growth at Supertel Hospitality (NASDAQ: SPPR) via acquisitions, leading to strong FFO upside, initiating shares with an Outperform rating and $8 target.

• ThinkEquity sees additional upside for Tarceva and started OSI Pharmaceuticals (NASDAQ: OSIP) with a Buy rating and $50 target.

• AG Edwards believes Brown-Forman (NYSE: BF.B) is well-positioned to benefit from new trends in spirits and wine, starting shares with a Buy rating and $74 target.

• RBC Capital is positive on NGAS Resources' (NASDAQ: NGAS) growth potential and high quality assets, starting shares with an Outperform rating and $11 target...

• CIT Group (NYSE: CIT) was started with a Market Perform rating at Keefe Bruyette.

• Oppenheimer started shares of Watsco, Inc (NYSE: WSO) with a Buy rating.

• ThinkEquity started Coley Pharmaceutical Group, Inc (NASDAQ: COLY) with an Accumulate rating and $10 target.

• Goldman initiated shares of Northwest Airlines Corp (OTC: NWACQ) with a Neutral rating and $26 target.

• Duetsche Bank initiated PPL Corp (NYSE: PPL) with a Buy rating and $51 target.

• Citigroup initiated Comverge, Inc (NASDAQ: COMV) with a Hold rating and $26 target.

Analyst initiations 5-24-07: BKC, NGAS, NWACQ and OSIP originally appeared on BloggingStocks on Thu, 24 May 2007 11:50:00 EST. Please see our terms for use of feeds.